Taimei Technology Completes 1.5 Billion Yuan Series E financing

According to Yiou, Taimei Technology announced the completion of its E round and an additional E round of financing, raising a total of 1.5 billion yuan, led by Tiger Global Management and Tencent, and joined by SB China Capital (SBCVC), Morningside Venture Capital, Cowin Venture, SAIF Partners, Zheshang Venture, Ivy Capital. 

After this round of financing, Taimei Technology will improve the construction of digital operation platform in the field of life sciences, build the infrastructure for the future operation of the pharmaceutical industry, and further expand its business in four fields, including pharmaceutical research and development, pharmacovigilance, market access, and pharmaceutical marketing.

Founded in 2013, Taimei Technology got 20 million yuan of A round financing in 2015, 30 million yuan of B round in 2016, and 100 million yuan of C round and 300 million yuan of D round in 2017.

As a leading technology solution provider in the field of life sciences, Taimei Technology is dedicated to propelling biopharmaceutical industry development through state-of-the-art information technology, with a focus in the field of clinical research and pharmacovigilance. 

Taimei Technology provides the cloud platform for seamless clinical research collaboration between sponsors, sites, CROs, patients, regulatory agencies and third-party providers. On the foundation of its platform are 6 technology-enabled solutions encompassing data management, project management, electronic regulatory submission, central medical imaging, pharmacovigilance, and drug logistics. With biopharma industry drug development pain points in mind, Taimei Technology is dedicated to improving R&D quality and efficiency for accelerating innovation time-to-market while reducing costs. 

Taimei Technology cooperates with pharmaceutical enterprises, CRO and research institutes. To date, the company has established close collaborations and strategic partnerships with over 200 leading local and global pharmaceutical companies and CRO. 

Founded in 2001, Tiger Global Management is an investment firm that deploys capital globally. It is based in New York with affiliate offices in Hong Kong, Singapore, Bangalore, and Melbourne. The firm’s fundamentally oriented investments focus primarily on the global Internet, technology, telecom, media consumer and industrial sectors. The private equity strategy has a ten-year investment horizon and targets growth-oriented private companies. The public equity efforts emphasize deep due diligence on individual companies and long-term secular themes.

Tencent is an internet service portal offering value-added internet, mobile, telecom, and online advertising services.

Since its establishment in 1998, Tencent has maintained steady growth under its user-oriented operating strategies. It provides value-added internet, mobile and telecom services, as well as online advertising under the strategic goal of providing users with "one-stop online lifestyle services." Tencent’s leading Internet platforms in China – QQ (QQ Instant Messenger), WeChat, QQ Games, Qzone, Tenpay and so on – aim to address the various needs of internet users, including communication, information, entertainment, e-commerce, and others.